NovaBay to Present New Case Studies on NeutroPhase(R) at the 2012 Spring Symposium on Advanced Wound Care – msnbc.com
April 16, 2012 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE AMEX:NBY), a biotech company developing novel anti ... any forward-looking statement except as required by law. CONTACT: NovaBay Business Development and Licensing ...
Subscribe to LegalLaw247.Com Newsletter